The MinDful PharmD Podcast
Welcome back to *The Refill*, your weekly dose of what’s new, what’s important, and what’s shaping the world of pharmacy and mental health. Today, we’re breaking down the top five stories from the past week—stories that matter for clinicians, caregivers, patients, and anyone who cares about the future of health. Let’s get into it. Until next time… Remember to breathe. Carry what matters. Let go of the rest and stay Mindful. References https://timesofindia.indiatimes.com/city/mysuru/jss-college-to-host-international-conference-on-sustainable-brain-health/articleshow/125351837.cms [https://timesofindia.indiatimes.com/city/mysuru/jss-college-to-host-international-conference-on-sustainable-brain-health/articleshow/125351837.cms] https://www.businessgrouphealth.org/newsroom/news-and-press-releases/press-releases/2025-employer-health-care-strategy-survey [https://www.businessgrouphealth.org/newsroom/news-and-press-releases/press-releases/2025-employer-health-care-strategy-survey] https://arxiv.org/abs/2510.10364 [https://arxiv.org/abs/2510.10364] https://news.ashp.org/News/ashp-news/2025/07/08/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health?utm_sourc [https://news.ashp.org/News/ashp-news/2025/07/08/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health?utm_source=chatgpt.com] https://nabp.pharmacy/news/news-releases/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health/ [https://nabp.pharmacy/news/news-releases/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health/] https://www.neurologyadvisor.com/news/fda-greenlights-caplyta-for-adjunctive-use-in-mdd/ [https://www.neurologyadvisor.com/news/fda-greenlights-caplyta-for-adjunctive-use-in-mdd/] https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder [https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder] https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder [https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder] Subscribe. Share. Rate. A thousand thanks! drmatmonharrell.bio.link [drmatmonharrell.bio.link] ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.
57 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The MinDful PharmD Podcast-Community!